Vitamin D Market is estimated to be US$ 3.08 billion by 2030 with a CAGR of 7.5% during the forecast period

June 8, 2022

Vitamins, minerals, enzymes, fatty acids, and proteins, among other dietary supplements, serve to maintain overall health and well-being by preventing nutritional deficiency disorders which drives the vitamin-D market. Dietary supplement preferences are expanding dramatically as a result of the global demographic trend of an ageing population, rising lifestyle-related disorders, and rising healthcare costs. Increased sales of sports nutrition due to rising fitness trends and sports activity, as well as new product introductions, are expected to have a substantial impact on the market. Dietary supplement health claims are receiving increased attention from regulatory agencies, and the business is becoming more regulated as a result. Dietary supplements are constantly developing to meet the needs of specialty populations (pregnant and breastfeeding women, geriatric, and pediatric nutrition), as well as government fortification projects around the world. Increased awareness of vitamin supplements has resulted in more positive attitudes toward the vitamin supplement sector.

Region Analysis:

Vitamin D insufficiency is common throughout Asia Pacific, notably in South and Southeast Asia. Rickets (a deformity caused by “soft bones”) is quite common in China and is caused by a lack of vitamin D. Furthermore, rising income levels and significant consumer demand for nutritional and healthy products are expected to provide promising prospects for the growth and diversification of the region’s functional food and beverage products, resulting in increased consumption of vitamin-infused products and, as a result, market growth. Due to increased demand for animal feed, fortified food items, and simple availability of raw materials, China and India are two of the most promising areas for vitamin D manufacturers to expand.

Key Development:

Zhejiang Xinhecheng Co., Ltd. (China) and DSM (Netherlands) inked a contract for the sale and purchase of cholesterol in January 2019. Vitamin D3 is made from cholesterol. This deal will assist the organisation in increasing its total capacity and Vitamin D productivity.
Fermenta Biotech Limited (India) signed a 99-year lease deal with the Gujarat Industrial Development Corporation (GIDC) authority in Ankleshwar, Sayakha, in January 2019 to acquire a 40,000-square-meter plot of land for future expansion. The company aims to commence manufacturing by the end of 2020.
Before purchasing this report, request a sample or make an inquiry by clicking the following link:


The Global Vitamin-D Market accounted for US$ 1.50 billion in 2020 and is estimated to be US$ 3.08 billion by 2030 and is anticipated to register a CAGR of 7.50%. The Global vitamin D market has been classified into analog, application, end-user, and region.

On the basis of analog, the target market is segmented into vitamin D2 and vitamin D3.
On the basis of application, the global vitamin D market has been bifurcated into functional food and beverages, pharmaceuticals, animal feed and pet food, and personal care.
On the basis of end-user, the target market is segmented into children, adults, and pregnant women.
Competitive Analysis:

Some of the prominent players operating in the global vitamin D market include Nestlé S.A., Pfizer, Inc., Koninklijke DSM N.V., ADM Alliance Nutrition, Inc., Abbott Nutrition Manufacturing Inc., GlaxoSmithKline plc, Cadila Pharmaceuticals Limited, Danone S.A., Kraft Foods Group, Inc., and Nature’s Bounty, Inc.

Article Tags:
Article Categories:

Leave a Comment

Your email address will not be published.